JP2609564B2 - Cream for allergic dermatitis and method for producing the same - Google Patents
Cream for allergic dermatitis and method for producing the sameInfo
- Publication number
- JP2609564B2 JP2609564B2 JP3156084A JP15608491A JP2609564B2 JP 2609564 B2 JP2609564 B2 JP 2609564B2 JP 3156084 A JP3156084 A JP 3156084A JP 15608491 A JP15608491 A JP 15608491A JP 2609564 B2 JP2609564 B2 JP 2609564B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- cream
- allergic dermatitis
- oak
- dermatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION
【0001】[0001]
【産業上の利用分野】 本発明はアレルギー性皮膚炎用
クリーム及びその製造法に関し、アレルギー、又特に金
属、化粧品、ウルシ等の接触性皮膚炎に有効なアレルギ
ー性皮膚炎用クリームに関するものである。The present invention relates to an allergic skin dermatitis <br/> cream and its preparation, allergies, and in particular metal, cosmetics, effective contact dermatitis such as lacquer allergy
Dermatitis cream.
【0002】[0002]
【従来の技術】 抗体が血清に認められず、細胞によっ
て仲介されるアレルギー反応をIV型のアレルギー反応
と呼ぶが、細菌、ウイルスカビ等の感染に伴う反応や、
金属、化粧品、ウルシ等の接触性皮膚炎などがこれに属
する。2. Description of the Related Art Cell-mediated allergic reactions in which antibodies are not found in serum and are called type IV allergic reactions include reactions associated with infections such as bacteria and viral mold,
Contact dermatitis such as metals, cosmetics, and urushi belong to this category.
【0003】然して細菌等の感染に伴う反応の場合には
細菌等の除去により対応策はあるが、アレルギー、接触
性皮膚炎には適当な対応治療法はステロイドホルモン以
外には提案されていない。[0003] In the case of a reaction associated with infection by bacteria or the like, there is a countermeasure by removing the bacteria or the like. However, no appropriate treatment other than steroid hormones has been proposed for allergy and contact dermatitis.
【0004】然して甘草根は古くから消炎効果がある薬
草として知られており、その有効成分であるグリチルリ
チン酸類は抗炎、抗アレルギー、抗消化性潰瘍作用など
のため、急性、慢性の皮膚炎の他、アフタ性口内炎など
に効果があるとして基礎化粧品や歯磨中に添加されてい
るものがある。However, licorice root has long been known as a medicinal herb having an anti-inflammatory effect, and its active ingredient glycyrrhizic acid has an anti-inflammatory, anti-allergic, anti-peptic ulcer effect, etc., so that acute and chronic dermatitis Others have been added to basic cosmetics and dentifrice as being effective for aphthous stomatitis and the like.
【0005】オウバクは、オウレン、オウゴンと共にベ
ルベリンを主成分とする生薬であるが、漢方に於ける用
法はオウレン、オウゴンと異なる場合が多い。オウバク
については消化器作用、眼疾患など殺菌作用を推測させ
る用法が多い。又、オウバクの薬効には外用剤としての
用法に特徴があり、ベルベリンは外用殺菌剤として単な
る殺菌作用では説明出来ない創面治療促進作用があると
報告されている。[0005] Oubak is a crude drug containing berberine as a main component together with spinach and ogon, but its usage in Chinese medicine is often different from spinach and ogon. There are many uses of oak for estimating bactericidal effects such as digestive effects and eye diseases. Also, the efficacy of oubaku is characterized by its use as an external preparation, and berberine is reported as a topical bactericide to have a wound healing promoting action that cannot be explained by mere bactericidal action.
【0006】クララはmatrineを主アルカロイド
とするもので、湿疹、水虫などの皮膚疾患、口内炎等に
用いられる[0006] Clara is mainly made of matrine and is used for skin diseases such as eczema and athlete's foot, stomatitis and the like.
【0007】[0007]
【発明が解決しようとする問題点】 しかしこれらは従
来漢方薬として使用され、いわゆる煎じ薬として使用さ
れるにすぎず、その一般的薬理については殆ど実験段階
であり、これらを組み合わせてその相乗効果をもたらす
使用方法は従来全く行われていなかった。[Problems to be Solved by the Invention] However, these are conventionally used as traditional Chinese medicines, only used as so-called decoctions, and their general pharmacology is almost an experimental stage, and a combination thereof produces a synergistic effect. The method of use has not been performed at all.
【0008】[0008]
【問題点を解決するための手段】 そこで本発明に於い
ては、皮膚障害治癒作用があり、抗アレルギー作用を有
するトリペノイト配糖体を6〜14%含有し、その代表
成分glycyrrhizinやglalricaci
d,gabrolide等数多くのサポゲニン、多数の
フラボノイド、フラボン類を利用できる甘草を配し、ベ
ルベリンを主成分とする生薬であるが、ベルベリンで代
表される薬効と明らかに相違するものがあり、又漢方に
おける用法も異なることが多いオウバクを、その成分を
有効に生かし、これに特に接触性皮膚炎に有効なアレル
ギー性皮膚炎用クリームに仕立てんとするもので、グリ
チルリチン酸を主体とする甘草抽出体を0.05〜0.
5%、オウバク抽出液を0.1〜10%、更にはクララ
抽出液を0.1〜10%を含有させることを特徴とする
アレルギー性皮膚炎用クリームと、基材のスクワラン、
ワセリン、流動パラフィンを加熱して混和溶解し、これ
に防腐剤を含む熱精製水を加えて乳化し、これにグリチ
ルリチン酸を主体とする甘草抽出体及びオウバク抽出
液、必要に応じクララ抽出液を加えた後、撹拌しながら
冷却させることを特徴とするアレルギー性皮膚炎用クリ
ームの製造方法を提案せんとするものである。[Means for Solving the Problems] Accordingly, in the present invention, 6 to 14% of a tripenoite glycoside having a skin disorder healing action and an antiallergic action is contained, and its representative components, glycyrrhizin and glallicaci, are contained.
It is a herbal medicine containing berberine as a main component, provided with licorice that can utilize many sapogenins such as d and gabrolide, many flavonoids, and flavones. A licorice extract mainly composed of glycyrrhizic acid, which makes use of its ingredients, which are often used differently, as a cream for allergic dermatitis, which is especially effective for contact dermatitis. From 0.05 to 0.
A cream for allergic dermatitis comprising 5%, 0.1-10% of an oak extract, and 0.1-10% of a Clara extract, and squalane as a base material;
Vaseline, miscible dissolved by heating liquid paraffin, this was emulsified by adding hot purified water containing preservatives, Gurichi thereto
A method for producing a cream for allergic dermatitis characterized by adding a licorice extract mainly composed of luritic acid, an oak extract and, if necessary, a Clara extract and then cooling while stirring. It is.
【0009】[0009]
【実施例】 以下、実施例により本発明を詳細に説明す
る。先ず、乳化剤としてモノステアリン酸グリセリン、
ポリオキシエチレン硬化ヒマシ油、防腐剤としてパラオ
キシ安息香酸ブチルを加熱して混和溶解する。これに防
腐剤パラオキシ安息香酸メチルを溶解した熱精製水を加
えて乳化する。これに甘草エキスであるが、glycy
rrhizinやそのゲニンのglycyrrheti
c acidは副腎皮質の水電解質や糖質ホルモン様作
用、エストロゲン作用、鎮咳作用、抗炎症作用、抗アレ
ルギー作用など数多くの薬理効果があるが、これを粧原
基として0.05〜0.5%まで含有させる。又、酸化
防止剤としてトコフェロール就中、酢酸−dl−α−ト
コフェロールを適量加える。Hereinafter, the present invention will be described in detail with reference to examples. First, glyceryl monostearate as an emulsifier,
Polyoxyethylene hydrogenated castor oil and butyl parahydroxybenzoate as a preservative are mixed and dissolved by heating. To this is added hot purified water in which a preservative, methyl parahydroxybenzoate, is dissolved to emulsify. This is licorice extract, but glycy
glycyrrheti of rrhizin and its genin
C acid has many pharmacological effects such as water electrolyte and carbohydrate hormone-like action of the adrenal cortex, estrogen action, antitussive action, anti-inflammatory action, anti-allergic action, and the like. To be contained. In addition, a suitable amount of tocopherol acetate-dl-α-tocopherol acetate is added as an antioxidant.
【0010】オウバクは殺菌作用を有すること前述した
が、ブドウ球菌に対し5%で発育阻止作用を認められ、
肺炎菌には最も強い抗菌力を示し、ベルベリン0.62
5%、オウバク末は0.015%の濃度まで阻止作用を
示した。As described above, oak has a bactericidal action, but a growth inhibitory action against staphylococci was observed at 5%.
B. pneumoniae has the strongest antibacterial activity, berberine 0.62
5% and oak powder showed an inhibitory effect up to a concentration of 0.015%.
【0011】又オウバクの薬効には単なる殺菌作用の強
さでは説明できない創面治癒作用があるが、例えばウサ
ギは背部皮膚に作成した筋肉に達した2cm2の新鮮創
傷の治癒はアクリノールに比べてベルベリン溶液処理群
が明らかに早かった。試験管での殺菌効力は明らかに合
成殺菌剤に比し弱いので、収斂性の抗炎症作用が治癒の
促進に関与しているものと思われる。又オウバクのアル
カロイド以外の成分としてリノール酸、パルミチン酸と
フィトステリンのエステルが同定されている。[0011] Although the efficacy of bark is the wound healing effects can not be explained by the strength of mere bactericidal action, for example, rabbits healing of fresh wounds 2 cm 2 was reached muscle created dorsal skin compared to Acrinol berberine The solution treatment group was clearly faster. Since the bactericidal efficacy in test tubes is clearly weaker than synthetic bactericides, it is likely that astringent anti-inflammatory effects are involved in promoting healing. In addition, esters of linoleic acid, palmitic acid and phytosterin have been identified as components other than oak alkaloids.
【0012】古来オウバク末は火傷、湯ただれに用いら
れ、近年では受精卵を用いた抗炎症作用のスクリーニン
グ研究に於て強い抵抗炎症作用が検出されている。即
ち、受精鶏卵の胚に検体を浸漬した瀘紙のディスクを作
用させ肉芽形成を阻害する作用を指標として活性を調べ
たところ、オウバクの50%メタノール抽出祖エキスは
500μg/diseの容量で53%の肉芽阻止作用を
した。塩酸ベルベリンは50μg/diseの容量で6
8.8%の抑制を示した。オウバクの炎症に関与する成
分は明確でない。日局オウバクの1.3ブチレングリコ
ール抽出液で、ベルベリンを塩化ベルベリンとして0.
15〜0.25w/v%含むものを使用し、全体の1〜
10%を含有させる。Since ancient times, powdered oak powder has been used for burns and soaking, and in recent years, a strong resistance inflammatory effect has been detected in screening studies of anti-inflammatory effects using fertilized eggs. That is, when the activity was examined using the filter paper disc in which the specimen was immersed in the embryo of the fertilized chicken egg to inhibit the formation of granulation, the 50% methanol-extracted extract of oak was 53% in the capacity of 500 μg / dise. Has a granulation inhibitory effect. Berberine hydrochloride is 6 at a volume of 50 μg / dise.
8.8% inhibition was shown. The components involved in oak inflammation are unclear. Berberine was converted to berberine chloride in a 1.3-butylene glycol extract of Oubaku Japan Pharmaceutical Co., Ltd.
Use those containing 15 to 0.25 w / v%,
Contains 10%.
【0013】クララはマメ化のsophora fla
vecens Aitonの根をそのまま50v/v%
エタノール溶液で抽出したものに1.3−ブチレングリ
コールと精製水の混液を加えたもので、アルカロイドの
主成分である(+)−matrine、副成分たる
(+)−oxynatrine等を含有し、又フラボノ
類としてXanthoumol、isoranthoh
amol等を含有する。これらは皮膚疾患、皮膚感染
症、あせも、ただれ、陰部掻痒症等に用いられる。又、
蛇床子と合わせると止痒効果が強まる。該クララ液を全
体の1〜10%を含有させる。Clara is a sophora fla
vecens Aiton root as it is 50v / v%
A mixture of 1.3-butylene glycol and purified water added to an ethanol-extracted solution, containing (+)-matrine, the main component of alkaloids, and (+)-oxynatrine, a minor component, and Xanthoumol, isolanthoh as flavonos
amol etc. They are used for skin diseases, skin infections, hot flashes, sores, genital pruritus and the like. or,
When combined with snakebed, itching effect is enhanced. The Clara liquor contains 1 to 10% of the whole.
【0014】前述の乳化剤に甘草エキス就中グリチルリ
チン酸ジカリウム、酸化防止剤の酢酸−dl−α−トコ
フェロール、オウバク抽出液、クララ抽出液を各1〜1
0%加えた後、撹拌しながら冷却し、製品を得る。The above-mentioned emulsifiers include licorice extract, especially dipotassium glycyrrhizinate, antioxidant dl-α-tocopherol acetate, oak extract and Clara extract, each having 1 to 1 part.
After adding 0%, the mixture is cooled with stirring to obtain a product.
【0015】〔実用例1〕 [Practical example 1]
【0016】〔実用例2〕 [Practical example 2]
【0017】〔実用例3〕 上記のクリームは止痒効果が優れていることが判明し
た。[Practical example 3] The above cream was found to have an excellent antipruritic effect.
【0018】各実用例について洗髪シャンプー、リンス
等に毎日接触しており、且つ、皮膚に炎症のある美容師
多数人に使用して頂いた処、その炎症にもよるが、早い
人で数日、遅い人でも数週間以内にかゆみがとれ、炎症
が治った、又は軽くなった。各実用例間の差については
症例が少なく、判明するのに時間が必要である。[0018] In each practical example, many hairdressers who are in daily contact with hair shampoos, rinses, etc. and have skin irritation have used it. Even within a few weeks, itching disappeared, and the inflammation healed or diminished. There are few cases of differences between the practical examples, and it takes time to find out.
【0019】下記に実用例3の使用例の効果を示す。実
用例3による手皮膚炎に対する有効率 The effects of the practical example 3 will be described below. Effective Rate for Hand Dermatitis by Practical Example 3
【0020】下記に実用例1の使用例の効果を示す。実
用例1による手皮膚炎に対する有効率 The effects of the usage example of practical example 1 will be described below. Effective Rate for Hand Dermatitis by Practical Example 1
【0021】又、各実用例ともアトピー性皮膚炎に対し
有効性が高いことが判明した。アレゲルンは単一でなく
複合的なものであるため、複合的な本品によって対症効
果がでる。又、これら実用例に対し、マレイン酸クロフ
ェニラミンを抗ヒスタミンとして配合したが、かゆみの
剌激が中和されて有効であることが判かった。It was also found that each of the practical examples was highly effective against atopic dermatitis. Allegern is not a single substance but a complex substance, so the combined use of this product provides a symptomatic effect. In addition, clophenylamine maleate was added as an antihistamine to these practical examples, but it was found that the stimulation of itching was neutralized and effective.
【0022】実施例2によるアトピー性皮膚炎の汗疹性
苔癬化型に対する有効率を示す。下段は坑ヒスタミン配
合の使用例を示す。 2 shows the effective rate of atopic dermatitis according to Example 2 against the lichenicus form of eczema. The lower part shows a usage example of the antihistamine compound.
【0023】[0023]
【発明の効果】 上記の如き本発明によれば、グリチル
リチン酸を主体とする甘草抽出体を0.05〜0.5
%、オウバク抽出液を1〜10%、必要に応じクララ抽
出液を1〜10%を含有させたアレルギー性皮膚炎用ク
リームを、基材のスクワラン、ワセリン、流動パラフィ
ンを加熱して混和溶解し、これに防腐剤を含む熱精製水
を加えて乳化し、これにグリチルリチン酸を主体とする
甘草抽出体及びオウバク抽出液、必要に応じクララ抽出
液を加えた後、撹拌しながら冷却させて製造するように
したので、甘草エキスの有する抗炎症作用、オウバク抽
出液の有するベルベリン、アルカロイド等による収斂状
の抗炎症作用を基とする創面治癒促進作用、抗炎症作
用、クララ抽出液の有する主アルカロイドのマトリンの
潰瘍発生予防能力、皮膚感染症の対応力等の夫々の能力
が組合わさり、夫々の効果と共に相乗効果を挙げ、極め
て優れたアレルギー性皮膚炎用クリームを提供すること
が出来る。According to the present invention as described above, a licorice extract mainly containing glycyrrhizic acid is used in an amount of 0.05 to 0.5.
%, Oak extract 1 to 10%, and Clara extract 1 to 10% as needed. The cream for allergic dermatitis is mixed and dissolved by heating squalane, petrolatum and liquid paraffin as base materials. Then, hot purified water containing a preservative is added to the mixture to emulsify the mixture, and glycyrrhizic acid-based licorice extract and oak extract, and Clara extract as needed, are added thereto , and then stirred. Since it is made to be manufactured by cooling, the anti-inflammatory effect of licorice extract, berberine of oak extract, a promotion of wound healing based on the convergent anti-inflammatory effect of alkaloids, etc., anti-inflammatory effect, Clara extract The major alkaloids possessed by Matrine combine their abilities to prevent ulcer occurrence and the ability to respond to skin infections. It is possible to provide a cream for over dermatitis.
Claims (3)
体を0.05〜0.5%、オウバク抽出液を1〜10%
を含有させることを特徴とするアレルギー性皮膚炎用ク
リーム。1. A licorice extract mainly composed of glycyrrhizic acid in an amount of 0.05 to 0.5% and an oak extract in an amount of 1 to 10%.
And a cream for allergic dermatitis .
ことを特徴とする請求項1に記載のアレルギー性皮膚炎
用クリーム。2. The allergic dermatitis according to claim 1, wherein the Clara extract contains 1 to 10%.
For cream.
ィンを加熱して混和溶解し、これに防腐剤を含む熱精製
水を加えて乳化し、これにグリチルリチン酸を主体とす
る甘草抽出体及びオウバク抽出液を、更に必要に応じク
ララ抽出液を加えた後、撹拌しながら冷却させることを
特徴とするアレルギー性皮膚炎用クリームの製造方法。3. Squalane, petrolatum and liquid paraffin as base materials are mixed and dissolved by heating, and hot purified water containing a preservative is added to the mixture for emulsification, and glycyrrhizic acid is mainly contained in the mixture .
A method for producing a cream for allergic dermatitis, characterized in that a licorice extract and oak extract are further added, if necessary, to a Clara extract and then cooled while stirring.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3156084A JP2609564B2 (en) | 1991-05-31 | 1991-05-31 | Cream for allergic dermatitis and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3156084A JP2609564B2 (en) | 1991-05-31 | 1991-05-31 | Cream for allergic dermatitis and method for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04356424A JPH04356424A (en) | 1992-12-10 |
| JP2609564B2 true JP2609564B2 (en) | 1997-05-14 |
Family
ID=15619953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3156084A Expired - Fee Related JP2609564B2 (en) | 1991-05-31 | 1991-05-31 | Cream for allergic dermatitis and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2609564B2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06247866A (en) * | 1993-02-22 | 1994-09-06 | Kazuyuki Sugawara | Skin damage prevention agent |
| US5482710A (en) * | 1993-07-30 | 1996-01-09 | Chesebrough-Pond'usa Co., Division Of Conopco, Inc. | Cosmetic composition for treatment of pimples and redness |
| CN1361694A (en) | 1999-07-16 | 2002-07-31 | 天藤制药株式会社 | Glycyrrhizin preparations for mucosal absorption |
| JP4555423B2 (en) * | 1999-12-22 | 2010-09-29 | 齋藤 政夫 | Anti-inflammatory cream |
| US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
| US20040142049A1 (en) * | 2001-07-17 | 2004-07-22 | Tatsumasa Mae | Compositions having tnf production inhibitory effect and tnf production inhibitors |
| EP1446167A4 (en) * | 2001-11-05 | 2010-09-29 | Orahealth Corp | Treating canker sores with patches to speed healing and relieve pain |
| KR100556286B1 (en) * | 2002-04-02 | 2006-03-03 | 전북대학교산학협력단 | Preparation method of beverage using herbal medicine and its beverage |
| WO2003086433A1 (en) * | 2002-04-15 | 2003-10-23 | Tetsuo Santo | Therapeutic cream for dermatitis |
| AU2002248030A1 (en) * | 2002-04-15 | 2003-10-27 | Tetsuo Santo | Cleanser |
| CN100340283C (en) * | 2002-04-15 | 2007-10-03 | 山东哲夫 | Therapeutic lotion for dermatitis |
| EP1686957B1 (en) * | 2003-11-17 | 2012-03-07 | Sederma | Compositions containing mixtures of tetrapeptides and tripeptides |
| JP6159084B2 (en) * | 2009-06-30 | 2017-07-05 | デルマン バイオメディシン カンパニー リミテッド | Composition containing berberine or an analogue thereof for treating skin diseases associated with rosacea or blush |
| CN109674849A (en) * | 2019-03-08 | 2019-04-26 | 胡宗银 | One kind tightens for female genital tract and anti-inflammatory composition |
| CN113893315A (en) * | 2021-11-25 | 2022-01-07 | 顾帆 | Anti-inflammation, detumescence and itching-relieving ointment for mosquito bites and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53136509A (en) * | 1977-05-04 | 1978-11-29 | Akira Hamaguchi | Production of dermatophytosis treating agent |
| JPS62292725A (en) * | 1986-06-12 | 1987-12-19 | Nitto Electric Ind Co Ltd | Remedy for insect bite |
| JP2609562B2 (en) * | 1991-05-27 | 1997-05-14 | 政夫 斎藤 | Cream for allergic dermatitis and method for producing the same |
-
1991
- 1991-05-31 JP JP3156084A patent/JP2609564B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04356424A (en) | 1992-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2609564B2 (en) | Cream for allergic dermatitis and method for producing the same | |
| JPH03190809A (en) | Skin external preparation | |
| MX2008012654A (en) | Novel compositions for hair disorders and process of preparation thereof. | |
| KR20220044764A (en) | External skin composition with anti-acne effect | |
| US12414976B2 (en) | Pharmaceutical composition for preventing hair loss or promoting hair growth, comprising ginsenoside RG4 or mixture (Rgx 365) of ginsenosides Rg2, Rg4, Rg6, and Rh1 as active ingredient | |
| JPH1036276A (en) | Antiallergic agent and antiallergic cosmetic material and food containing the same | |
| JP3611128B2 (en) | Testosterone-5-α-reductase inhibitor | |
| Kaban et al. | The effect of turmeric parent extract gel (Curcuma longa Linn) on incision wound healing in male white rats (Rattus norvegicus) | |
| JP2609562B2 (en) | Cream for allergic dermatitis and method for producing the same | |
| JP2002370998A (en) | Ceramide production promoter | |
| US9987322B1 (en) | Treatment of pain in peripheral neuropathy using topical hamelia patens extract | |
| JP2609563B2 (en) | Cream for allergic dermatitis and method for producing the same | |
| KR101202178B1 (en) | Pharmaceutical composition containing leaves and fruits of phellodendron amurense | |
| KR102214985B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
| KR20150096165A (en) | Manufacturing method for cosmetic composition for improving acne and cosmetic compostion thereof | |
| KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
| KR102272771B1 (en) | Cosmetic composition for alleviating sebum secretion comprising Carthamus tinctorius extract or mixture extract of Carthamus tinctorius and Areca catechu | |
| JPH05286835A (en) | Hair-raising cosmetic | |
| EP0348215B1 (en) | Novel cosmetic and paramedicinal compositions | |
| JPH04124138A (en) | External preparation for skin | |
| JPH06128136A (en) | Skin external preparation | |
| JP3142309B2 (en) | Hair restorer | |
| JPH03161423A (en) | Hair tonic | |
| KR0154648B1 (en) | Hair growth and restoration promoter | |
| AU2021104419A4 (en) | Polyherbal Gel formulation for growth of Hair Follicle |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 19961022 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090213 Year of fee payment: 12 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100213 Year of fee payment: 13 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110213 Year of fee payment: 14 |
|
| LAPS | Cancellation because of no payment of annual fees |